Totowa, NJ – October 12, 2016 —– BiologicTx® announced today, a successful, single-center, 6-way kidney transplant exchange at the Houston Methodist J.C. Walter Transplant Center in Houston, Texas.
Totowa, NJ – September 22, 2016 —– BiologicTx® today announced their three year clinical transplant desensitization outcomes that demonstrate that desensitization with IVIg allows patients to reach transplant with a low risk of AMR and excellent allograft function, post-transplant.
Totowa, NJ – June 28, 2016 —– BiologicTx® today announced that their Paired Donation Software, BiologicTx MatchGrid™, has been implemented internationally at the King Faisal Specialist Hospital and Research Centre in Riyadh, Saudi Arabia under the supervision of Dr. Khalid Almeshari.
Totowa, NJ – June 10, 2016 — BiologicTx ® today announced the enhanced release of their Paired Donation Software, BiologicTx MatchGrid™ which includes a brand new feature called Knockout Avoids. Knockout Avoids provides virtual desensitization by simulating the removal of incompatible antibodies, which can be barriers to transplantation.
Totowa, NJ – January 5, 2016 — BiologicTx®, a transplant-focused specialty pharmacy, today appointed Andrea Z. Zachary, PhD, Diplomate, ABHI, and Mary S. Leffell, PhD, Diplomate, ABMLI, ABHI, to its Medical Advisory Board as Co-Directors of Science for the BiologicTx Kidney Paired Donation Program. In their new role, Drs. Zachary and Leffell will work with BiologicTx’s proprietary matching software, BiologicTx MatchGrid™ in several respects, including evaluating match runs between participating transplant centers, both domestically and internationally, and enhancing related software development.
Totowa, NJ – December 1, 2015 — BiologicTx®, a transplant-focused specialty pharmacy, today announced that they have access to Veloxis Pharmaceuticals’ new product Envarsus® XR (tacrolimus extended-release tablets).
Totowa, NJ – September 2, 2015 — BiologicTx® today announced the acquisition of Sunshine Infusion Services, Inc., in the greater Chicago, IL area.
Totowa, NJ – July 1, 2015 — BiologicTx® announced their four year transplant desensitization outcomes which demonstrated Continued Deceased Donor Desensitization Success.
Totowa, NJ – June 10, 2015 — BiologicTx® today announced that their Paired Donation matching software, BiologicTx MatchGrid™, was the driving force behind pairing up the eighteen donors and recipients in the nine-way kidney exchange that took place on June 4th and June 5th at Sutter Health’s California Pacific Medical Center (CPMC) and UCSF Medical Center. This is believed to be the first time a transplant event of this size was completed in the same city over a period of 36 hours.
Totowa, NJ – March 11, 2015 – BiologicTx® today announced that their Paired Donation Software, MatchGrid, was the platform responsible for matching up the donor and recipient pairs in the successful 6-way kidney paired donation transplant conducted at California Pacific Medical Center (CPMC) on March 5th and 6th, 2015. Initiated by an altruistic donor, this transplant marks the first successful single-center exchange of this magnitude on the West
Totowa, NJ – July 28, 2014 – BiologicTx® announced their Discovery 2 Life™ (D2L™), a leading digital health platform designed to guide and support hospitals, clinicians and patients throughout the organ transplant continuum. D2L supports aspects of the organ transplant process, including organization of data associated with enrolling a transplant candidate into a desensitization therapeutic program, donor data management (including identifying optimal donors from a paired donation pool), management of post-transplant therapies including immunosuppressive, antiviral, and rejection medications. From a single data source, all key information is organized and available to all physicians involved, histocompatibility laboratories, pharmacists and nurses.
Totowa, NJ – July 17, 2014 – BiologicTx® today announced their participation in Florida’s first 3-way Kidney Paired Donation transplant exchange utilizing BiologicTx’s proprietary matching software, MatchgridTM. The landmark surgical procedures happened on July 9 at the Miami Transplant Institute, located at Jackson Memorial Hospital in Miami, Fla.
Totowa, NJ – July 17, 2014 – BiologicTx® was selected as the specialty pharmacy for the observational treatment registry study to evaluate the long-term treatment effects of immune globulin intravenous (IGIV) maintenance therapy on donor specific antibodies (DSA) in renal transplant recipients. Study sponsors are Databean of Mount Vernon, NY and eMax Health of White Plains, NY.
Totowa, NJ – July 9, 2014 – BiologicTx® today announced the acquisition of Injectable Therapy Services, Inc., in Los Angeles, California, near the UCLA Campus. Injectable Therapy Services (ITS) provides solid organ transplant and other specialty pharmacy services nationally, including biologic, oral, and outpatient therapies through their Infusion Center and in the patient’s home.
Outcome Intended To Demonstrate Improvement in Overall Rate Of Kidney Transplantation in Sensitized Patients
Totowa, NJ – May 12, 2014 – BiologicTx® today announced the initiation of an observational clinical study to determine if a combination of desensitization and enrollment in a regional paired donor kidney (KPD) exchange program improves the overall rate of kidney transplantation in sensitized patients. This study is being conducted at five transplant centers in the Northwest region of the United States including: Swedish Medical Center, the University of Washington, Virginia Mason Medical Center, Oregon Health and Science University, and Providence Sacred Heart Medical Center and Children’s Hospital and is sponsored by BiologicTx®
Expanding Paired Donation and IT Platform
Totowa, NJ – Nov 18, 2013 – BiologicTx®, announced today the recent acquisition of Silverstone Solutions, Inc. and their Kidney Paired Donation software, Silverstone Matchgrid, as part of their continuing expansion. Silverstone Matchgrid is a sophisticated proprietary software application that assists clinicians in accurately matching individuals awaiting kidney transplants with viable living kidney donors who are incompatible with their intended recipients.
BiologicTx Sequence™ Enables Transplant Clinicians to Better Understand the Therapeutic Impact of Progressive and Routine Protocols while Ensuring Compliance
Totowa, NJ – May 18, 2013 – BiologicTx®, the first solely focused infusion and pharmacy provider of biologic and oral transplant therapy management, today announced the unveiling of their new proprietary transplant therapeutic data management and analytics program, BiologicTx Sequence™. BiologicTx Sequence is a proprietary data management system that combines a patient’s drug therapy interventions with patient specific data to provide the clinician with a global picture of the therapeutic impact and efficacy of the treatment prescribed. BiologicTx Sequence aggregates into a unified database all physician, laboratory, pharmacy and nursing data into one, easy to use and manage database that optimizes patient care.